Neurocrine Biosciences
NBIX
NBIX
218 hedge funds and large institutions have $4.7B invested in Neurocrine Biosciences in 2015 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 92 increasing their positions, 72 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more funds holding
Funds holding: 207 → 218 (+11)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
218
Holding in Top 10
4
Calls
$36.2M
Puts
$28.1M
Top Buyers
| 1 | +$48.9M | |
| 2 | +$37.1M | |
| 3 | +$23.6M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$22.5M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$22.2M |
Top Sellers
| 1 | -$73.6M | |
| 2 | -$25.3M | |
| 3 | -$21.3M | |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
-$18M |
| 5 |
Millennium Management
New York
|
-$15.1M |